NOVO NORDISK A/S revenue breakdown overview

NOVO NORDISK A/S revenue for the last year amounted to 36.50 B CHF, the most of which — 34.16 B CHF — came from its highest performing source at the moment, Diabetes and Obesity Care, the year earlier bringing 26.81 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought NOVO NORDISK A/S 21.04 B CHF, and the year before that — 15.89 B CHF.